Genzyme Takes On Sandoz Over Renagel ANDA
Genzyme Corp. has targeted Sandoz Inc, the generics arm of Novartis AG, in its latest effort to keep a generic version of Renagel off the market before the expiration of its...To view the full article, register now.
Already a subscriber? Click here to view full article